Association between systemic inflammatory response index and left ventricular remodeling and systolic dysfunction in

Runze Chi1, Xiaoli Shan1, ChunPing Guan1

  • 1Qingdao Municipal Hospital, Qingdao University Affiliated Qingdao Municipal Hospital, 266011, Qingdao, Shandong, China.

PubMed

Insights

The systemic inflammatory response index (SIRI) is linked to cardiac remodeling and dysfunction in atrial fibrillation (AF) patients. Higher SIRI levels indicate a greater risk of impaired heart structure and function in individuals with AF.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Atrial fibrillation (AF) is a common arrhythmia that can lead to cardiac remodeling and impaired systolic function.
  • Inflammation plays a crucial role in the pathophysiology of cardiovascular diseases, including AF.

Purpose of the Study:

  • To investigate the association between the systemic inflammatory response index (SIRI) and left ventricular (LV) remodeling and systolic function in patients with AF.
  • To evaluate SIRI as a potential biomarker for cardiac dysfunction in AF.

Main Methods:

  • A retrospective study included 416 patients diagnosed with AF.
  • The systemic inflammatory response index (SIRI) was calculated using the formula: neutrophil count × monocyte count / lymphocyte count.
  • Cardiac parameters, including LV dimensions, mass, ejection fraction, and left atrial (LA) diameter, were assessed.

Main Results:

  • SIRI showed significant correlations with multiple cardiac parameters, including LV end-diastolic diameter, LV posterior wall thickness, interventricular septal thickness, LV mass index (LVMI), LV ejection fraction (LVEF), and LA diameter (LAD).
  • Multivariate analyses revealed SIRI's significant association with LVMI, LVEF, and LAD.
  • The highest quartile of SIRI was significantly linked to LV hypertrophy, impaired LV systolic function, and LA enlargement.

Conclusions:

  • The systemic inflammatory response index (SIRI) is significantly associated with left ventricular remodeling and systolic function impairment in patients with atrial fibrillation.
  • SIRI may serve as a practical and dependable inflammatory biomarker for identifying cardiac structural and functional abnormalities in individuals with AF.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
27
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10